ArticleClinical and experimental medicine2025
Enhancing antioxidant capacity and reducing asthma risk: the impact of zinc and iron on molecular pathways.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma is a complex chronic inflammatory disease with unclear causal links to micronutrients such as zinc and iron. Two-sample Mendelian randomization (MR) analyses, integrated with bioinformatics, were conducted to assess the associations of circulating zinc and iron levels with asthma risk. Analysis of data from Open GWAS and FinnGen demonstrated that each 1-SD increase in circulating zinc levels was associated with a modest reduction in asthma risk (OR = 0.947, 95% CI = 0.902–0.994, p = 0.029), while each 1-SD increase in circulating iron levels was similarly associated with lower risk (OR = 0.782, 95% CI = 0.652–0.937, p = 0.008). Multivariable MR confirmed a statistically significant but limited protective association for zinc (OR = 0.944, p = 0.039), whereas the association for iron was not significant (OR = 0.776, p = 0.227). Bioinformatic analyses indicated that key genes in the NRF2/HO-1 and NF-κB pathways are linked to asthma severity, suggesting potential molecular mechanisms underlying trace metal effects. Collectively, these findings support a potential causal role of zinc and iron in asthma and motivate targeted mechanistic and clinical trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.